1887

Abstract

The primary multiplication site of VVTGgRAB, a recombinant vaccinia virus (VV) expressing the rabies virus G glycoprotein, was studied in comparison with that of the parental VV Copenhagen strain, after oral administration to foxes. Foxes were fed with 10 TCID of either VVTGgRAB or VV and were sacrificed 12, 24, 48 or 96 h after inoculation. Both viruses were detected by viral isolation in the tonsils during the first 48 h after inoculation at titres between 10 and 10 TCID/ml. Indirect immunofluorescence confirmed the presence of the virus in tonsils of some of the foxes. The polymerase chain reaction allowed the detection of VVTGgRAB in the tonsils of both of two foxes tested after 24 h, three of three foxes after 48 h, in the buccal mucosa of one of two foxes tested after 24 h and two of three foxes after 48 h and in the soft palate of one of two foxes tested after 24 h and one of three foxes after 48 h. VV was detected in the tonsils of one fox tested after 48 h, in the buccal mucosa of another fox tested after 24 h, and in the first fox after 48 h by the same reaction. Foxes were inoculated with virus isolated from fox tonsils 24 h after oral administration (with or without cell culture amplification) to perform back passages. No virus could be isolated in either case after this passage. The innocuity of VVTGgRAB was also demonstrated when foxes were inoculated with passaged virus.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-71-1-37
1990-01-01
2021-10-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/71/1/JV0710010037.html?itemId=/content/journal/jgv/10.1099/0022-1317-71-1-37&mimeType=html&fmt=ahah

References

  1. Anilionis A., Wunner W. H., Curtis P. 1981; Structure of the glycoprotein gene of rabies virus. Nature; London: 294275–278
    [Google Scholar]
  2. Blancou J., Kieny M. P., Lathe R., Lecocq J. P., Pastoret P.-P., Soulebot J. P., DeSmettre P. 1986; Oral vaccination of the fox against rabies using a live recombinant vaccinia virus. Nature; London: 322373–375
    [Google Scholar]
  3. Blancou J., Artois M., Brochier B., Thomas I., Pastoret P.-P., Desmettre P., Languet B., Kieny M. P. 1989; Innocuité et efficacité du virus recombinant vaccine-rage administré par voie orale chez le renard, le chien et le chat. Annales de Recherches Vétérinaires 20:195–204
    [Google Scholar]
  4. Brochier B., Thomas I., Iokem A., Ginter A., Kalpers J., Paquot A., Costy F., Pastoret P.-P. 1988a; A field trial in Belgium to control fox rabies by oral immunization. Veterinary Record 123:618–621
    [Google Scholar]
  5. Brochier B., Languet B., Blancou L, Lecocq J. P., Costy F., Desmettre P., Pastoret P.-P. 1988b; Use of a recombinant vaccinia-rabies virus for oral vaccination of fox cubs (Vulpes vulpesL.) against rabies. Veterinary Microbiology 18:103–108
    [Google Scholar]
  6. Brochier B., Blancou J., Thomas I., Languet B., Artois M., Kieny M. P., Lecocq J. P., Costy F., Desmettre P., Pastoret P.-P. 1989; Use of recombinant vaccinia-rabies glycoprotein virus for oral vaccination of wildlife against rabies : innocuity to several non-target bait consuming species. Journal of Wildlife Disease (in press)
    [Google Scholar]
  7. Buller R. M. L., Smith G. L., Cremer K., Notkins A. L., Moss B. 1985; Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature; London: 317813
    [Google Scholar]
  8. Hanlon C. A., Ziemers E. L., Hamir A. N., Rupprecht C. E. 1989; Cerebrospinal fluid analysis of rabies and vaccinia-rabies glycoprotein recombinant in orally vaccinated raccoons (Procyon lotor). American Journal of Veterinary Research 50:364–367
    [Google Scholar]
  9. Kärber G. 1931; Beitrag zur kollectiven Behandlung Pharmakologischer Reiherversuche. Archive für experimentelle Pathologie und Pharmakologie 162:480–483
    [Google Scholar]
  10. Kieny M. P., Lathe R., Drillien R., Spehnbr D., Skory S., Schmitt D., Wiktor T., Koprowski H., Lecocq J. P. 1984; Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature; London: 312163–166
    [Google Scholar]
  11. Lane J. M., Ruben F. L., Neff J. M., Millard J. D. 1969; Complications of smallpox vaccination, 1968: results of ten statewide surveys. Journal of Infectious Diseases 122:303–309
    [Google Scholar]
  12. Leblois H., Flamand A. 1988; Studies on pathogenicity in mice of rabies virus strains used for oral vaccination of foxes in Europe. In Vaccination to Control Rabies in Foxes pp 101–104 Pastoret P.-P., Brochier B., Thomas I., Blancou J. Edited by Brussels: Office for Official Publications of the European Communities;
    [Google Scholar]
  13. Maniatis T., Fritsch E. F., Sambrook J. 1982 Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  14. Pastoret P.-P., Frisch R., Blancou J., Brochier B., Wolff F., Roboly O., Schneider L. G. 1987; Campagne internationale de vaccination antirabique du renard par voie orale menée au grand-duché de Luxembourg, en Belgique et en France. Annales de Médecine Vétérinaire 131:441–447
    [Google Scholar]
  15. Pastoret P.-P., Brochier B., Languet B., Thomas I., Paquot A., Bauduin B., Kieny M. P., Lecocq J. P., DeBruyn J., Costy F., Antoine H., Desmettre P. 1988; First field trial of fox vaccination against rabies using a vaccinia-rabies recombinant virus. Veterinary Record 123:481–483
    [Google Scholar]
  16. Rupprecht C. E., Wiktor T. J., Johnston D. H., Hamir A. N., Dietzschold B., Wunner W. H., Glickman L. T., Koprowski H. 1986; Oral immunization and protection of raccoons (Procyon lotor)with a vaccinia-rabies glycoprotein recombinant virus vaccine. Proceedings of the National Academy of Sciences U. S.A: 837947–7950
    [Google Scholar]
  17. Rupprecht C. E., Hamir A. N., Johnston D. H., Koprowski H. 1988; Efficacy of a vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor). Research Towards Rabies Prevention, Reviews of Infectious Disease 10:S803–S808
    [Google Scholar]
  18. Saiki R. K., Scharf S., Faloona F., Mullis K. B., Horn G. T., Erlich H. A., Arnheim N. 1985; Enzymatic amplification of βglobin genomic sequence and restriction site analysis for diagnoses of sickle cell anemia. Science 230:1350–1354
    [Google Scholar]
  19. Schneider L. G., Cox J. H. 1983; Ein Feldversuch zur oralen immunisierung von Füchsen gegen die Tollwut in der Bundesrepublik Deutschland. I. Unschädlichkeit, Wirksamkeit und Stabilität der Vakzine SAD B19. Tierärztliche Umschau 38:315–324
    [Google Scholar]
  20. Soria Baltazar R., Blancou J., Artois M. 1987; Résultats de l’administration par voie orale au mouton de deux vaccins contenant un virus de la rage modifié (S AD B19) ou un recombinant du virus de la vaccine et de la rage (187XP). Annales de Médecine Vétérinaire 131:481–486
    [Google Scholar]
  21. Steck F., Wandeler A.L, Capt S., Schneider L. 1982; Oral immunization of foxes against rabies. A field study. Zentralblatt für Veterinärmedizin 29:372–396
    [Google Scholar]
  22. Tolson N. D., Charlton K. M., Stewart R. B., Campbell J. B., Wiktor T. J. 1987; Immune response in skunks to a vaccinia virus recombinant expressing the rabies virus glycoprotein. Canadian Journal of Veterinary Research 51:363–366
    [Google Scholar]
  23. Tolson N. D., Charlton K. M., Casey G. A., Knowles M. K., Rupprecht C. E., Lawson K. F., Campbell J. B. 1988; Immunization of foxes against rabies with a vaccinia recombinant virus expressing the rabies glycoprotein. Archives of Virology 102:297–301
    [Google Scholar]
  24. Wandeler A., Wachendorfer G., Forster U., Krekel H., Muller J., Steck F. 1972; Rabies in wild carnivores in Central Europe. II. Virological and serological examinations. Zentralblatt für Veterinärmedizin B21:757–764
    [Google Scholar]
  25. Weir J. P., Moss B. 1983; Nucleotide sequence of vaccinia virus TK gene. Journal of Virology 46:530–537
    [Google Scholar]
  26. Wiktor T. J., Kieny M. P., Lathe R. 1988; New generation of rabies vaccine. Vaccinia rabies glycoprotein recombinant virus. In Applied Virology Research I New Vaccines and Chemotherapy pp 69–89 Kurstak E., Marusyk R. G., Murphy F. A., Van Regenmortel M. H. V. Edited by New York: Plenum Press;
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-71-1-37
Loading
/content/journal/jgv/10.1099/0022-1317-71-1-37
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error